The reported improved sensitivity of drug-resistant P. berghei k173 to ART with artemisinin-chrysosplenetin combination may be because ART activates the expression of intestinal P-gp and Abcb1/Abcg2 and inhibits the expression of breast cancer resistance protein, whereas chrysosplenetin reverses these expressions [56]. Here, ABCG2 is linked to cancer.